Catatan bukti metode

Adaptive Phase IV study

An Adaptive Phase IV study is a post-marketing surveillance study conducted after a drug or intervention has received regulatory approval, augmented with pre-specified adaptive design elements that allow pre-planned modifications to the study protocol in response to accumulating data. These modifications may include sample size re-estimation, endpoint adjustments, or population enrichment, all governed by statistical rules set before the study begins, preserving scientific integrity while increasing efficiency.

Sources recorded, not reviewed

Catatan sumber

Kutipan disalin apa adanya dari catatan sumber metode. Tidak ada verifikasi tingkat klaim yang disimpulkan darinya.

Adaptive Phase IV Post-Marketing Study

Catatan metode taksonomi · process-pipeline / epidemiology

Chow, S. C., & Chang, M. (2008). Adaptive Design Methods in Clinical Trials. Chapman and Hall/CRC. · ISBN 978-1584889625
U.S. Food and Drug Administration. (2019). Adaptive Designs for Clinical Trials of Drugs and Biologics: Guidance for Industry. FDA. · URL

Buka metode lengkap

Klaim yang dikurasi

Klaim tersimpan dalam buku besar bukti, masing-masing dengan penilaiannya sendiri.

Belum ada klaim yang dikurasi

Tampilan ini tidak menciptakan penilaian klaim ketika buku besar tidak memilikinya.

Metode terkait

Dihasilkan dari grafik metode dan ditampilkan sebagai relasi yang disarankan mesin — tidak ada klaim bukti yang disimpulkan.

Taxonomic bucketAdaptive Phase III clinical trialmachine-suggested · Relational suggestion, not evidence.Taxonomic bucketAdaptive Randomized Clinical Trialmachine-suggested · Relational suggestion, not evidence.Taxonomic bucketBayesian Phase IV studymachine-suggested · Relational suggestion, not evidence.Taxonomic bucketCohort Studymachine-suggested · Relational suggestion, not evidence.Taxonomic bucketPhase IV studymachine-suggested · Relational suggestion, not evidence.Taxonomic bucketPragmatic phase IV studymachine-suggested · Relational suggestion, not evidence.